未找到相关数据
A multicenter, open-label phase II trial of secondline apatinib plus irinotecan in patients with advanced gastric cancer
被引：1
作者：
Peng, Jianjun
Li, Yong
Xiao, Jianjun
Liu, Huaqiang
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Tradit Chinese Med Hosp Guangdong Prov, Guangzhou, Peoples R China
[3] Zhongshan City Peoples Hosp, Zhongshan, Peoples R China
[4] Cent Hosp Guangdong Prov Agr Reclamat, Zhanjiang, Guangdong, Peoples R China
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.287
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287
引用
收藏
页数：3
相关论文